GS at it again in AFR:Goldman updates ASX lithium stock ratings
Tom Richardson
Goldman Sachs notes the Australian lithium sector’s total market cap has run from $15 billion to $60 billion in just two years thanks to soaring lithium prices. However, it said it expects lithium prices to fall over the second half of 2023 and into 2024 as the supply and demand outlook rebalances.
Core Lithium chief executive Gareth Manderson.
It has initiated coverage on Allkem with a buy rating and $15.20 price target, and Core Lithium with a sell rating and $1 price target.
Goldman is also buy rated on Mineral Resource, with neutral ratings on Pilbara Minerals, Independence Group, and Liontown.
“The team expect the China lithium carbonate spot (excl. VAT) price path through 1H23 to reflect the near-term tightness and lagging spodumene contract price pass-through before a decline over the second half of next year to put the 2023 average at ~US$53,300/t LCE (vs. US$16,372/t LCE previously), though their forecast of a sharp reprice lower in 2024 remains unchanged (GSe US$11,000/t) on the SD [supply/demand] outlook,” the broker said
- Forums
- ASX - By Stock
- CXO - Chart Thread
GS at it again in AFR:Goldman updates ASX lithium stock...
-
- There are more pages in this discussion • 4,325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.3¢ |
Change
0.003(2.50%) |
Mkt cap ! $219.6M |
Open | High | Low | Value | Volume |
10.5¢ | 10.8¢ | 10.3¢ | $314.0K | 2.991M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
203 | 11206359 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 1462807 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
203 | 11205459 | 0.100 |
7 | 297503 | 0.099 |
13 | 250749 | 0.098 |
5 | 298728 | 0.097 |
7 | 574914 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 1462807 | 34 |
0.110 | 4641821 | 39 |
0.115 | 2807042 | 38 |
0.120 | 7775985 | 63 |
0.125 | 4586671 | 56 |
Last trade - 11.38am 12/11/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online